This Article Full Text Full Text (PDF) All Versions of this Article: 200712-1841OCv1 177/10/1122    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Condliffe, R. Articles by Pepke-Zaba, J. Search for Related Content PubMed PubMed Citation Articles by Condliffe, R. Articles by Pepke-Zaba, J.

Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension

¹ Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United Kingdom; ² Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom; ³ Department of Cardiology, Hammersmith Hospital, London, United Kingdom; ⁴ Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom; ⁵ Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom; ⁶ Scottish Pulmonary Vascular Unit, Western Infirmary, Glasgow, United Kingdom; and ⁷ Department of Cardiology, Royal Free Hospital, London, United Kingdom

Correspondence and requests for reprints should be addressed to Dr. Joanna Pepke-Zaba, Ph.D., Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge CB23 3RE, UK. E-mail: joanna.pepkezaba{at}papworth.nhs.uk

Rationale: The management of chronic thromboembolic pulmonary hypertension (CTEPH) has changed over recent years with the growth of pulmonary endarterectomy surgery and the availability of disease-modifying therapies.

Objectives: To investigate the prognosis of CTEPH in a national setting during recent years.

Methods: All incident cases diagnosed in one of the five pulmonary hypertension centers in the United Kingdom between January 2001 and June 2006 were identified prospectively. Information regarding baseline characteristics, treatment, and follow-up was subsequently collected from hospital records.

Measurements and Main Results: A total of 469 patients received a diagnosis, of whom 148 (32%) had distal, nonsurgical disease. One- and three-year survival from diagnosis was 82 and 70% for patients with nonsurgical disease and 88 and 76% for those treated surgically (P = 0.023). Initial functional improvement in patients with nonsurgical disease was noted but did not persist at 2 years. Significant functional and hemodynamic improvements were seen in surgically treated patients with an increase in six-minute-walk distance of 105 m (P < 0.001) at 3 months. Five-year survival from surgery in the 35% of patients who survived to 3 months but had persistent pulmonary hypertension was 94%.

Conclusions: The prognosis in nonsurgical disease has improved. We have confirmed the previously described good outcome in surgically treated disease. However, we have also demonstrated that the long-term prognosis for patients who have persistent pulmonary hypertension at 3 months after surgery is good. The observed improvements in outcome during the modern treatment era reinforce the importance of identifying patients with this increasingly treatable condition.

Key Words: pulmonary hypertension • thromboembolism • endarterectomy • survival • drug therapy

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Chronic thromboembolic pulmonary hypertension (CTEPH) occurs in up to 3.8% of patients after an acute pulmonary embolism. Historically, outcome was poor, but it has improved significantly in patients suitable for pulmonary endarterectomy. What This Study Adds to the Field Prognosis in nonsurgical CTEPH has improved. Long-term outcome in patients with persistent pulmonary hypertension at follow-up after pulmonary endarterectomy is good.

 

This article has been cited by other articles:

				Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537. [Full Text] [PDF]

				C. M. Kahler Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history Eur. Respir. Rev., September 1, 2009; 18(113): 170 - 173. [Abstract] [Full Text] [PDF]

				M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S85 - S96. [Abstract] [Full Text] [PDF]

				M. Humbert Update in Pulmonary Hypertension 2008 Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 650 - 656. [Full Text] [PDF]

				I. M. Lang Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Eur. Respir. Rev., March 1, 2009; 18(111): 24 - 28. [Abstract] [Full Text] [PDF]

				F. Couturaud, I. Frachon, and C. Leroyer Chronic thromboembolic pulmonary hypertension: a tribute to pulmonary endarterectomy Eur. Respir. J., February 1, 2009; 33(2): 230 - 232. [Full Text] [PDF]

				M. K. Johnson, W. N. Lee, M. W. Sproule, and A. J. Peacock Regional variations in pulmonary endarterectomy rates within the UK Eur. Respir. J., February 1, 2009; 33(2): 453 - 454. [Full Text] [PDF]

				R. Condliffe, D. G. Kiely, J. S. R. Gibbs, P. A. Corris, A. J. Peacock, D. P. Jenkins, K. Goldsmith, J. G. Coghlan, and J. Pepke-Zaba Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Eur. Respir. J., February 1, 2009; 33(2): 332 - 338. [Abstract] [Full Text] [PDF]

				X. Jais, A. M. D'Armini, P. Jansa, A. Torbicki, M. Delcroix, H. A. Ghofrani, M. M. Hoeper, I. M. Lang, E. Mayer, J. Pepke-Zaba, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2127 - 2134. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF]

				A. G. Corsico, A. M. D'Armini, I. Cerveri, C. Klersy, E. Ansaldo, R. Niniano, E. Gatto, C. Monterosso, M. Morsolini, S. Nicolardi, et al. Long-term Outcome after Pulmonary Endarterectomy Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 419 - 424. [Abstract] [Full Text] [PDF]